Relapse-Free Survival
Showing 1 - 25 of >10,000
Survival in Adult MRD Positive Acute Lymphoblastic Leukemia
Completed
- Acute Lymphoblastic Leukemia
-
Brno, Czechia
- +9 more
Sep 12, 2022
Biochemical Relapse Free Survival, Complications Rates (Erectile Dysfunction, GI, GU Complications) Trial in St Petersburg
Recruiting
- Biochemical Relapse Free Survival
- Complications Rates (Erectile Dysfunction, GI, GU Complications)
- Stereotactic ablative radiotherapy
- High dose rate brachytherapy
-
St Petersburg, Russian FederationSergey Novikov
Apr 28, 2021
Prognostic Factors Affecting Recurrence and Disease-Free
Recruiting
- Rectal Cancer
- curative surgery for cancer rectum
-
QinÄ, EgyptQena Faculty of Medicine, South Valley University Hospitals
Oct 21, 2023
Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)
Not yet recruiting
- Metastatic Prostate Cancer
- (no location specified)
Mar 6, 2023
Severe Toxicity Free Survival Following Childhood Acute
Recruiting
- Acute Lymphoblastic Leukemia
-
Copenhagen, DenmarkKjeld Schmiegelow
Dec 9, 2022
Crestal Bone Loss, Survival Rate Trial in Cairo (placement of dental implants)
Completed
- Crestal Bone Loss
- Survival Rate
- placement of dental implants
-
Cairo, EgyptAin Shams University
Oct 21, 2023
Improving Liver Transplant-free Survival in Acute Decompensation
Not yet recruiting
- Decompensated Cirrhosis
- No intervention
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Jul 12, 2023
Ovarian Cancer Trial in Roma (Blood samples)
Not yet recruiting
- Ovarian Cancer
- Blood samples
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Oct 3, 2023
Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)
Not yet recruiting
- Renal Cell Carcinoma
- Neoadjuvant
- Axitinib plus Toripalimab
- radical nephrectomy
- (no location specified)
Feb 12, 2023
Disease-free Survival of High-risk Head-neck Cutaneous Squamous
Active, not recruiting
- Carcinoma, Squamous Cell
- +5 more
- Treatment
-
Maastricht, Netherlands
- +1 more
Apr 26, 2023
Prostate Cancer, Node; Prostate, Radiotherapy Side Effect Trial in Quebec (Report and compare changes in a non-inferiority
Recruiting
- Prostate Cancer
- +2 more
- Report and compare changes in a non-inferiority analysis of the International Prostate Symptom Score (I-PSS)
- +7 more
-
Quebec, CanadaCHUdeQuebec
Apr 7, 2023
Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant
Completed
- The Primary Study Metric is Progression-free Survival (PFS)
- (no location specified)
Jun 28, 2023
Smoking, Tobacco Use, Lung Cancer Trial in Tampa (Nicotine patch and lozenges, Telephone counseling sessions, Access to a
Active, not recruiting
- Smoking
- +2 more
- Nicotine patch and lozenges
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 9, 2023
Textbook Outcome in Colon Carcinoma
Completed
- Outcome Assessment
- Cancer of Colon
- Colon oncological resection
-
Alicante, SpainHospital General Universitario Dr. Balmis
Jan 5, 2023
Meningioma, Meningioma Atypical, Anaplastic Meningioma Trial in Rome (Biological biomarker assessment)
Recruiting
- Meningioma
- +2 more
- Biological biomarker assessment
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 29, 2023
Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,
Recruiting
- Stem Cell Transplant Complications
- +4 more
- Radiation
- +7 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally
Recruiting
- to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
- Capecitabine 500Mg Oral Tablet
-
Shanghai, ChinaEye & ENT Hospital, Fudan University
Jul 2, 2023
Overall Survival, Progression-free Survival, Cost Trial (Microwave Ablation)
Completed
- Overall Survival
- +2 more
- Microwave Ablation
- (no location specified)
Apr 1, 2023
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul
Active, not recruiting
- Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Primary Non-metastatic Breast Cancer, Who Remain Disease-free Trial in Lyon, Villejuif (Everolimus, Placebo)
Active, not recruiting
- Primary Non-metastatic Breast Cancer
- Who Remain Disease-free
- Everolimus
- Placebo
-
Lyon, France
- +1 more
Feb 23, 2022
Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)
Terminated
- Breast Neoplasms
- Doxorubicin
- +7 more
-
Saint Louis, MissouriWashington University School of Medicine
Oct 31, 2022
Disease Free Survival, Overall Survival, Pancreatic Cancer Trial in Milan (use of targeted drugs such as aspirin, B-Blockers,
Recruiting
- Disease Free Survival
- +2 more
- use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins
-
Milan, ItalyIRCCS San Raffaele
Mar 7, 2022
Progression-free Survival Trial (Sovalteinib Solutumab Tegeo)
Not yet recruiting
- Progression-free Survival
- Sovalteinib Solutumab Tegeo
- (no location specified)
Jul 24, 2023
Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery
Recruiting
- Prostate Cancer
- +6 more
- Radiotherapy (SBRT) and/or surgery (metastasectomy)
- +2 more
-
Leuven, BelgiumUniversity Hospitals Leuven
Jun 7, 2022
Bladder Cancer, Bladder Urothelial Carcinoma Trial in Toronto (re-TURBT, 6 weeks BCG instillation)
Terminated
- Bladder Cancer
- Bladder Urothelial Carcinoma
- re-TURBT
- 6 weeks BCG instillation
-
Toronto, Ontario, CanadaUniversity Health Network
Apr 12, 2022